Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:289643.
doi: 10.1155/2014/289643. Epub 2014 Feb 23.

Assessment of Premutation in Myotonic Dystrophy Type 1 Affected Family Members by TP-PCR and Genetic Counseling

Affiliations

Assessment of Premutation in Myotonic Dystrophy Type 1 Affected Family Members by TP-PCR and Genetic Counseling

Ashok Kumar et al. Case Rep Med. 2014.

Abstract

Myotonic dystrophy type 1 (DM1) is caused by the expansion of an unstable CTG repeat located in the 3'-UTR of (DMPK) the DM protein kinase gene. Patients with DM1 have expansions of greater than 50 repeats and up to many thousands. In the present study we aimed to evaluate the utility of TP-PCR in diagnostics as well as the assessment of premutation carriers in proband families. Twenty-seven DM1 cases were enrolled (from twenty-six families) and the 13 families of these cases came forward for family screening. The patient group constitute 22 males and 5 females and the average age of onset was 32.8 years (range 17 to 52). All clinically diagnosed DM1 cases and their family members DNA samples were analyzed by TP-PCR. All the cases were found to be positive for the CTG repeat expansion. Among those five families, four had at least an asymptomatic carrier. In the remaining one family other than the proband none was found to be neither affected nor asymptomatic. We reconfirmed the utility of PCR based screening for DM1 as being reliable and rapid molecular test and it should be used as an initial screening test for all patients with DM and their family members for initial screening purpose.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Case 1 (P2): I-1, I-2, II-2, and II-3 were proband's father, mother, younger sister, and younger brother, and II-1 was DM1 patient. Square = male; circle = female; black symbol = patient (II-1); and black dots in symbols represent asymptomatic carriers (proband's mother, I-2, and younger sister, II-2). (b) Case 2 (P7): I-2, III-2, and III-3 all were normal and II-1, II-3, II-4, and III-1 were asymptomatic carriers. (c) Case 3 (P8): II-2 was DM1 patient and III-1 (first daughter) was asymptomatic carrier for DM1. (d) Case 4 (P10) screening: all relatives of the proband were normal for disease. (e) Case 5 (P13): proband father (I-1) was asymptomatic while all were normal for disease.

Similar articles

Cited by

References

    1. Harper PS . ,Myotonic Dystrophy. London, UK: WB Saunders; 1989.
    1. Meola G, Sansone V. Cerebral involvement in myotonic dystrophies. Muscle and Nerve. 2007;36(3):294–306. - PubMed
    1. Mankodi A. Myotonic disorders. Neurology India. 2008;56(3):298–304. - PubMed
    1. Meola G, Bugiardini E, Cardani R. Muscle biopsy. Journal of Neurology. 2012;259(4):601–610. - PubMed
    1. Reardon W, Newcombe R, Fenton I, Sibert J, Harper PS. The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects. Archives of Disease in Childhood. 1993;68(2):177–181. - PMC - PubMed

LinkOut - more resources